Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SYNAPTICS Inc Director's Dealing 2017

Jun 2, 2017

31479_dirs_2017-06-01_77b36d30-a80b-4d38-98a9-d4987e59390f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SYNAPTICS Inc (SYNA)
CIK: 0000817720
Period of Report: 2017-05-31

Reporting Person: Bergman Rick (Director, President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-05-31 Common Stock M 10000 $23.25 Acquired 105728 Direct
2017-05-31 Common Stock S 9200 $55.5334 Disposed 96528 Direct
2017-05-31 Common Stock S 800 $56.4913 Disposed 95728 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-05-31 Employee Stock Option (Right to Buy) $23.25 M 10000 Disposed 2018-09-28 Common Stock (10000) Direct

Footnotes

F1: Includes 240 shares acquired under the Issuer's employee stock purchase plan in May 2017.

F2: The shares were sold pursuant to a 10b5-1 Trading Plan dated August 22, 2016.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.04 to $56.02, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.09 to $56.60, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

F5: 25% of the total number of shares subject to the option vested and became exercisable on the twelve month anniversary of the September 28, 2011 grant date, and 1/48th of the total number of shares subject to the option vested and became exercisable on the 28th day of each month thereafter, until fully vested on September 28, 2015.